𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sustained-release of levodopa: single dose study of a new formulation

✍ Scribed by M. Gerlach; W. Kuhn; Th. Müller; P. Klotz; H. Przuntek

Publisher
Springer
Year
1996
Tongue
English
Weight
788 KB
Volume
103
Category
Article
ISSN
1435-1463

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A comparative bioavailability study on t
A comparative bioavailability study on two new sustained-release formulations of disodiummonofluorophosphate versus a nonsustained-release formulation in healthy volunteers
✍ L. Erlacher; H. Templ; D. Magometschnigg 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 436 KB

In 12 healthy volunteers the pharmacokinetic parameters of two new sustained-release formulations of disodiummonofluorophosphate (MFP) (B and C) were compared with those of a nonsustained-release reference preparation (A). This randomized study had a single-dose, triple-cross over design and consist

Comparative pharmacokinetics of ketoprof
Comparative pharmacokinetics of ketoprofen derived from single oral doses of ketoprofen capsules or a novel sustained-release pellet formulation
✍ G. W. Houghton; M. J. Dennis; E. D. Rigler; R. L. Parsons 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 349 KB

Nine healthy male volunteers took part in a crossover study to compare the pharmacokinetics of ketoprofen after administration of a single oral dose (200mg) of ketoprofen as 'Orudis' capsules or encapsulated sustained-release pellets, 'Oruvail'. The mean f standard deviation values for highest obse

Simultaneous modelling of mexiletine and
Simultaneous modelling of mexiletine and hydroxy-methyl-mexiletine data after single- and multiple-dose administration of a sustained-release mexiletine formulation
✍ R. Bruno; Y. Santoni; A. Iliadis; P. Djiane; A. Serradimigni; J. P. Cano 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 566 KB

## Abstract The pharmacokinetics of mexiletine and its metabolite hydroxy‐methyl‐mexiletine have been investigated following single‐dose and during multiple‐dose administration of a sustained‐release form of mexiletine to six post‐myocardial infarct patients. Comparison of single‐dose and washout p